According to Zen Score, the 3 best drug store stocks to buy right now are:
1. Walgreens Boots Alliance (NASDAQ:WBA)
Walgreens Boots Alliance (NASDAQ:WBA) is the top pharmaceutical retailer stock with a Zen Score of 43, which is 21 points higher than the pharmaceutical retailer industry average of 22. It passed 16 out of 38 due diligence checks and has strong fundamentals. Walgreens Boots Alliance has seen its stock lose -36.19% over the past year, overperforming other pharmaceutical retailer stocks by 33 percentage points.
Walgreens Boots Alliance has an average 1 year
price target of $24.14, an upside of 14.86% from Walgreens Boots Alliance's current stock price of $21.02.
Walgreens Boots Alliance stock has a consensus Hold recommendation according to Wall Street analysts. Of the 7 analysts covering Walgreens Boots Alliance, 14.29% have issued a Strong Buy rating, 0% have issued a Buy, 57.14% have issued a hold, while 14.29% have issued a Sell rating, and 14.29% have issued a Strong Sell.
2. High Tide (NASDAQ:HITI)
High Tide (NASDAQ:HITI) is the second best pharmaceutical retailer stock with a Zen Score of 25, which is 3 points higher than the pharmaceutical retailer industry average of 22. It passed 8 out of 33 due diligence checks and has weak fundamentals. High Tide has seen its stock return 79.13% over the past year, overperforming other pharmaceutical retailer stocks by 148 percentage points.
High Tide has an average 1 year
price target of $4.50, an upside of 118.45% from High Tide's current stock price of $2.06.
High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Trxade Health (NASDAQ:MEDS)
Trxade Health (NASDAQ:MEDS) is the third best pharmaceutical retailer stock with a Zen Score of 23, which is 1 points higher than the pharmaceutical retailer industry average of 22. It passed 8 out of 38 due diligence checks and has weak fundamentals. Trxade Health has seen its stock return 39.93% over the past year, overperforming other pharmaceutical retailer stocks by 109 percentage points.